Ceftaroline Fosamil Injection, Powder, Lyophilized, For Solution
Product Images NDC 60505-6124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ceftaroline Fosamil (NDC 60505-6124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label-400mg-10s.jpg (Carton Label 400mg 10s)

Carton-label-400mg-10s.jpg (Carton Label 400mg 10s)
Ceftaroline Fosamil for Injection 400 mg per vial, lyophilized powder for intravenous infusion by Apotex Corp. The label indicates single-dose vials, 10 per package, requiring further dilution before intravenous infusion. Manufactured by QILU Pharmaceutical Co., Ltd. in China for Apotex Corp. The packaging includes dosage, storage, and preparation instructions along with barcode and regulatory information.*
FDA Label Image

Carton-label-600mg-10s.jpg (Carton Label 600mg 10s)

Carton-label-600mg-10s.jpg (Carton Label 600mg 10s)
Packaging label for Ceftaroline Fosamil for Injection 600 mg/vial, injection powder lyophilized for solution, intended for intravenous infusion. The label indicates it contains 10 single-dose vials and is manufactured for Apotex Corp. It provides storage instructions and dilution information, with the manufacturer identified as QILU Pharmaceutical Co., Ltd., China.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient Ceftaroline Fosamil, showing its molecular framework with multiple rings, functional groups including phosphate, amide, and carboxylate moieties, as well as the presence of a methylpyridinium group associated with acetic acid.*
FDA Label Image

Vial-label-400mg.jpg (Vial Label 400mg)

Vial-label-400mg.jpg (Vial Label 400mg)
Label for Ceftaroline Fosamil 400 mg/vial injection, powder, lyophilized for solution. Intended for intravenous infusion, single-dose vial, manufactured by QILU Pharmaceutical Co., Ltd. and labeled for Apotex Corp. Provides instructions for constitution and storage and displays the NDC 60505-6124-0.*
FDA Label Image

Vial-label-600mg.jpg (Vial Label 600mg)

Vial-label-600mg.jpg (Vial Label 600mg)
Label for Ceftaroline Fosamil for Injection 600 mg/vial, a lyophilized powder for intravenous infusion. The label includes instructions for constitution with 20 mL diluent, storage conditions, and manufacturing information by QILU Pharmaceutical Co., Ltd. for Apotex Corp. It is a single-dose vial with discard after use warning and an NDC number 60505-6125-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.